Factors affecting colonization and dissemination of Candida albicans from the gastrointestinal tract of mice

Male ICR Swiss mice (2 to 3 months old) were fed Candida albicans in their drinking water for 3 days, followed by no treatment, antibiotics in their drinking water (daily), or immunosuppressants given by intraperitoneal injection (two to three times weekly) over a 3- to 4-week period. The organs of animals were processed to determine the numbers of C. albicans and total aerobic bacteria per g of tissue. Untreated animals had mean Candida counts during the 1-month period of 10(2.3) CFU/g of cecum. Animals in six of eight antibiotic-treated groups had mean cecal Candida counts higher than those of control animals (P less than 0.05), with clindamycin-gentamicin producing the highest counts (10(4.7) CFU/g). Cyclophosphamide produced counts (10(4.3) CFU/g) which were higher (P less than 0.05) than those resulting from methotrexate (10(3.0) CFU/g) or steroid (10(2.7) CFU/g) treatment. Cyclophosphamide-clindamycin-gentamicin treatment was associated with the highest (P less than 0.05) levels of Candida colonization (10(6.5) CFU/g). Mice receiving immunosuppressants plus clindamycin-gentamicin were more likely to disseminate C. albicans than were mice receiving antibiotics alone (P less than 0.001). Our findings suggest that colonization of the guts of mice by C. albicans can be facilitated by manipulating the aerobic, anaerobic, or both types of gut flora. The combined effect of immunosuppressants on both Candida gut colonization and dissemination appears multifactorial and deserves further investigation.

[1]  G. Cole,et al.  Systemic and gastrointestinal candidiasis of infant mice after intragastric challenge , 1979, Infection and immunity.

[2]  S. Gorbach,et al.  Studies of intestinal microflora. I. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man. , 1967, Gastroenterology.

[3]  R. Myerowitz,et al.  Disseminated candidiasis. Changes in incidence, underlying diseases, and pathology. , 1977, American journal of clinical pathology.

[4]  D. Citron,et al.  Impact of cefoperazone therapy on fecal flora , 1982, Antimicrobial Agents and Chemotherapy.

[5]  J. Hamilton-miller Antimicrobial activity of 21 anti-neoplastic agents. , 1984, British Journal of Cancer.

[6]  C. Herrera,et al.  Effects of compromising agents on candidosis in mice with persistent infections initiated in infancy , 1982, Infection and immunity.

[7]  D. Ahearn,et al.  Fungal flora of the normal human small and large intestine. , 1969, The New England journal of medicine.

[8]  D. Bjorkman,et al.  Esophageal, gastric, and intestinal candidiasis. , 1984, The American journal of medicine.

[9]  D. Bryk,et al.  Idiopathic intestinal pseudo-obstruction. , 1975, American Journal of Gastroenterology.

[10]  M. J. Kennedy,et al.  Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism , 1985, Infection and immunity.

[11]  R. Donaldson Small bowel bacterial overgrowth. , 1970, Advances in internal medicine.

[12]  Trier Js,et al.  Interim analysis of a comparative trial of ranitidine and cimetidine in the prevention of duodenal ulcer. , 1984 .

[13]  P. Sherlock,et al.  Candida infection of the gastrointestinal tract. , 1972, Medicine.

[14]  J. Jorgensen,et al.  Antibacterial activities of antineoplastic agents , 1985, Antimicrobial Agents and Chemotherapy.

[15]  P. Wiernik,et al.  Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis. , 1975, Annals of internal medicine.

[16]  H. Goldberg,et al.  Idiopathic intestinal pseudo-obstruction. , 1972, The American journal of roentgenology, radium therapy, and nuclear medicine.